Immutep Ltd (NASDAQ:IMMP)

2.35
Delayed Data
As of Jun 22
 +0.0053 / +0.23%
Today’s Change
1.25
Today|||52-Week Range
3.06
+49.68%
Year-to-Date
No recent news for Immutep Ltd.

Today’s Trading

Previous close2.34
Today’s open2.44
Day’s range2.30 - 2.44
Volume31,404
Average volume (3 months)68,825
Market cap$51.1M
Data as of 3:59pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+83.16%
Earnings growth (this year)-7.25%
Earnings growth (next 5 years)+0.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.18

Competitors

 Today’s
change
Today’s
% change
AEZSAEterna Zentaris Inc-0.02-0.95%
PRTOProteon Therapeutics...+0.15+5.77%
HTGMHTG Molecular Diagno...-0.07-2.01%
FSIFlexible Solutions I...-0.06-3.59%
Data as of 4:00pm ET, 06/22/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$7.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Marc Voigt
COO, Secretary &
General Counsel
Deanne Miller
Corporate headquarters
Sydney, New South Wales (nsw)

Forecasts